EP0040224A1 - An improved method of non homogenous enzyme immunoassay - Google Patents
An improved method of non homogenous enzyme immunoassayInfo
- Publication number
- EP0040224A1 EP0040224A1 EP80902222A EP80902222A EP0040224A1 EP 0040224 A1 EP0040224 A1 EP 0040224A1 EP 80902222 A EP80902222 A EP 80902222A EP 80902222 A EP80902222 A EP 80902222A EP 0040224 A1 EP0040224 A1 EP 0040224A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- enzyme
- analogue
- ligand
- antibody
- analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
Definitions
- AN IMPROVED METHOD OF NON HOMOGENOUS ENZYME IMMUNOASSAY This invention relates to an improved method of the technique known as non homogenous enzyme immunoassa , described, for example, in “Quantitative Enzyme Immunoassay", Ed. E. Engvall and A.J. Pesce, Blackwood Scientific Publications (Scand. J. Immunol. 8, Suppl. 7, 1978) .
- non homogenous enzyme immunoassay is based on the competition for the active site of an anti ⁇ body between a ligand and a covalently coupled derivative of that same ligand to an enzyme. With separation of the bound and free enzyme ligand phases, enzyme assay of either fraction can then be made. To aid in the separation of the phases, it is often convenient to bind the antibody to an insoluble particle such as the wall of the reaction vessel itself, or a polysaccharide particle. Plotting of the percent bound against the ligand concentration, results in a typical immunoassay curve.
- the enzyme immunoassay system is also capable of simple modification to provide for the measurement of serum antibody levels by making enzyme-anti- body derivatives and using a solid phase ligand to assist in the separation step.
- the antibody characteristics required for the development of a successful non homogenous enzyme immunoassay for a particular ligand are those of high specificity for the ligand, as well as a high apparent affinity constant (as 1/mol) for the ligand.
- an antibody demonstrating a high specificity and a high affinity constant towards a particular ligand will also bind substances which are closely similar in chemical structure to the ligand itself. Such substances are herein referred to as "analogues of the ligand”.
- the affinity constant of the antibody observed with respect to the analogue may differ markedly from that observed for the antibody with the ligand itself. It is the object of
- the present invention provides a method of non homogenous enzyme immunoassay including the steps of: (i) binding an analogue of a ligand to an enzyme to form an enzyme-ligand analogue complex; (ii) contacting the enzyme-ligand analogue complex with antibody for the ligand so as to bind the complex to the antibody;
- a suitable analogue of the ligand is selected such that it is bound specifically by the antibody, though to a much lower affinity than is the case for the original ligand itself.
- Such an analogue is then covalently joined to an appropriat enzyme by known methods of chemistry.
- preparations of the antib are linked by appropriate means to an insoluble particle which may be the surface of the inner wall of the small tube or may be a small insoluble particle, such as a polysaccharide or a glass bead.
- an insoluble particle which may be the surface of the inner wall of the small tube or may be a small insoluble particle, such as a polysaccharide or a glass bead.
- Such a "formed solid phase” antibody is required to retain its function as an antibody.
- the enzyme-labelled analogue is then brought into contact with the solid phase antibody, such that all the binding sites of the solid phase antibody are occupied by the enzyme-labelled analogue. Such an.
- enzyme-labelled analogue may then be displaced from the binding site of the solid phase antibody by addition under appropriate conditions of the original ligand to which the antibody has been derived, or a different analogue having a higher affinity for the antibody than the enzyme-labelled analogue.
- liberated enzyme analogue By separation of the liberated enzyme analogue from the enzyme analogue remaining bound to the solid phases , it is found that the quantity of liberated enzyme analogue, as measured by whatever means, bears an analytical relation ⁇ ship to the quantity of antigen or other ligand which causes the displacement.
- the amount of enzyme analogue liberated by known concentration of ligand in appropriate standards, the measurement of an unknown concen ⁇ tration of the ligand in a sample can be effected.
- known amounts of the enzyme-labelled analogue bound to the antibody can be dispensed into vials and subjected to the process known as freeze-drying.
- freeze-drying By adding a required volume of water to the vial to reconstitute the active enzyme-analogue-antibody-complex, the assay can then be performed directly.
- appropriate precautions to maintain stability of the reagent it would be possible to utilise a previously defined calibration curve from which the amount of ligand in a sample can be calculated without the necessity of so performing a calibration curve at that time. This method thus has application in times of emergency when speed
- an assay for the anti- epilepsy drug dilantin, in the patients taking this drug is described.
- Antibodies were raised to dilantin in goats by appropriate means and the antibodies demonstrated an affinity for dilantin of 10 1/mole, while having an affini for meth l-dilantin of 10 1/mole.
- Methyl dilantin was the covalently joined to bacterial beta-galactosidase using water soluble carbo-dii ide, and the antibody covalently bound to sepharose beads. Aliquots of the sepharose antibo methyl dilantin-beta-galactosidase complexes were formed an all available antibody binding sites saturated.
- Tube No. Dilantin Cont b-Galactosidase activity (Mg/L) (A405/min/ml)
- ligand or ligand analogue such as the systems phenobarbitone (meta-nitro phenobarbitone) theophylline (l-methyl-3-carboxy butyl xanthine) thyroxine (3,3' 5 - triiodo-5 '-bromo thyronine) and triiodothyronine (3,5 - diiodo-3'-bromo thyronine).
- phenobarbitone metal-nitro phenobarbitone
- theophylline l-methyl-3-carboxy butyl xanthine
- thyroxine l-methyl-3-carboxy butyl xanthine
- thyroxine l-methyl-3-carboxy butyl xanthine
- thyroxine l-methyl-3-carboxy butyl xanthine
- thyroxine l-methyl-3-carboxy butyl x
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Procede d'analyse immunologique d'enzymes non homogenes dont l'etape initiale consiste a lier un analogue de liant a une enzyme pour former un complexe enzyme-liant. Ce complexe est ensuite mis en contact d'un anticorps du liant de maniere a y lier le complexe. L'analogue d'enzyme peut alors etre deplace des sites de liaison de l'anticorps par adjonction du liant de depart pour lequel l'anticorps a ete derive ou d'un analogue different possedant une specificite plus elevee pour l'anticorps que l'analogue marque par l'enzyme. Ensuite, l'analogue d'enzyme libere est separe de l'analogue lie a l'anticorps et une certaine quantite d'analogue enzymatique liberee est mesuree determinant ainsi la quantite de liant dans un echantillon par comparaison de la quantite d'analogue d'enzyme liberee avec des concentrations connues de liant.A method of immunoassay for non-homogeneous enzymes the initial step of which is to bind a binder analog to an enzyme to form an enzyme-binder complex. This complex is then contacted with an antibody to the binder so as to bind the complex to it. The enzyme analog can then be moved from the antibody binding sites by adding the starting binder for which the antibody was derived or a different analog having higher specificity for the antibody than the analog marked by the enzyme. Next, the released enzyme analog is separated from the antibody-bound analog and a certain amount of released enzyme analog is measured, thereby determining the amount of binder in a sample by comparison to the amount of analog of enzyme released with known concentrations of binder.
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU1374/79 | 1979-11-19 | ||
AUPE137479 | 1979-11-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0040224A1 true EP0040224A1 (en) | 1981-11-25 |
EP0040224A4 EP0040224A4 (en) | 1982-09-09 |
Family
ID=3768341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19800902222 Withdrawn EP0040224A4 (en) | 1979-11-19 | 1980-11-19 | An improved method of non homogenous enzyme immunoassay. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0040224A4 (en) |
JP (1) | JPS56501583A (en) |
WO (1) | WO1981001414A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3626468A1 (en) * | 1986-08-05 | 1988-02-11 | Hoechst Ag | METHOD AND TEST KIT FOR DETERMINING FREE ACTIVE INGREDIENTS IN BIOLOGICAL LIQUIDS |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2184371A5 (en) * | 1972-05-11 | 1973-12-21 | Akzo Nv | |
GB1401297A (en) * | 1971-05-14 | 1975-07-16 | Syntex Energy Res | Enzyme aplification assay |
US3966764A (en) * | 1972-07-10 | 1976-06-29 | Syva Company | Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs |
FR2348493A1 (en) * | 1976-04-15 | 1977-11-10 | Technicon Instr | IMMUNOTEST FOR DIPHENYL-HYDANTOINE |
GB1575610A (en) * | 1976-04-15 | 1980-09-24 | Technicon Instr | Immunoassay for diphenylhydantoin |
EP0026103A1 (en) * | 1979-09-24 | 1981-04-01 | AMERSHAM INTERNATIONAL plc | A method for determining the free portion of substances in biological fluids |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3673410A (en) * | 1969-06-25 | 1972-06-27 | John H Waite | Method of examination of cell samples using a radioactively tagged dye |
US3905871A (en) * | 1971-05-14 | 1975-09-16 | Syva Co | Lactam conjugates to enzymes |
US3852157A (en) * | 1971-05-14 | 1974-12-03 | Syva Corp | Compounds for enzyme amplification assay |
US3817837A (en) * | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
DE2128670B2 (en) * | 1971-06-09 | 1977-06-30 | Merck Patent Gmbh, 6100 Darmstadt | IMMUNOLOGICAL ISOENZYME DETERMINATION METHOD |
US3975237A (en) * | 1972-11-06 | 1976-08-17 | Syva Company | Compounds for enzyme amplification assay - - ecgonine analogs |
US3966556A (en) * | 1972-11-06 | 1976-06-29 | Syva Company | Compounds for enzyme amplification assay methadone analogs |
IN142734B (en) * | 1975-04-28 | 1977-08-20 | Miles Lab | |
JPS5925183B2 (en) * | 1978-07-05 | 1984-06-15 | ダイナボット株式会社 | Method for measuring elastase-1 |
US4273866A (en) * | 1979-02-05 | 1981-06-16 | Abbott Laboratories | Ligand analog-irreversible enzyme inhibitor conjugates and methods for use |
-
1980
- 1980-11-19 EP EP19800902222 patent/EP0040224A4/en not_active Withdrawn
- 1980-11-19 JP JP50264580A patent/JPS56501583A/ja active Pending
- 1980-11-19 WO PCT/AU1980/000090 patent/WO1981001414A1/en not_active Application Discontinuation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1401297A (en) * | 1971-05-14 | 1975-07-16 | Syntex Energy Res | Enzyme aplification assay |
GB1401298A (en) * | 1971-05-14 | 1975-07-16 | Syntex Energy Res | Ligands bonded to enzymes |
FR2184371A5 (en) * | 1972-05-11 | 1973-12-21 | Akzo Nv | |
GB1433783A (en) * | 1972-05-11 | 1976-04-28 | Akzo Nv | Process for the detection and determination of haptens |
US3966764A (en) * | 1972-07-10 | 1976-06-29 | Syva Company | Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs |
FR2348493A1 (en) * | 1976-04-15 | 1977-11-10 | Technicon Instr | IMMUNOTEST FOR DIPHENYL-HYDANTOINE |
GB1575610A (en) * | 1976-04-15 | 1980-09-24 | Technicon Instr | Immunoassay for diphenylhydantoin |
EP0026103A1 (en) * | 1979-09-24 | 1981-04-01 | AMERSHAM INTERNATIONAL plc | A method for determining the free portion of substances in biological fluids |
Non-Patent Citations (1)
Title |
---|
See also references of WO8101414A1 * |
Also Published As
Publication number | Publication date |
---|---|
JPS56501583A (en) | 1981-10-29 |
EP0040224A4 (en) | 1982-09-09 |
WO1981001414A1 (en) | 1981-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4143124A (en) | Antigen-antibody analysis with solid phase rf and c1q | |
US4434236A (en) | Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue | |
US4481298A (en) | Pre-precipitated double antibody immunoassay method | |
US4427781A (en) | Particle agglutination immunoassay with agglutinator for determining haptens; PACIA | |
EP0177191A1 (en) | Methods of assay | |
Miedema et al. | Determinations of proteins and hormones in serum by an immunoassay using antigen-enzyme conjugates | |
JPS6311627B2 (en) | ||
CA1145672A (en) | Polyethylene glycol in double antibody radioimmunoassay | |
JPS6255103B2 (en) | ||
CA2046130A1 (en) | Biologically active reagent, analytical element and methods for use of the reagent | |
US4283383A (en) | Analysis of biological fluids | |
US4128629A (en) | Extraction-free cortisol assay | |
US4052504A (en) | Assay for thyroxine binding globulin | |
EP0303229B1 (en) | Method of high sensitivity immunoassay | |
EP0095089B1 (en) | Improved homogeneous binding assay method and reagent system, test kit and test device therefor | |
US5376557A (en) | Process for the determination of antibodies which are class-specific for an antigen and a reagent for carrying out the process | |
NO164135B (en) | IMMUNOMETRIC METHOD FOR DETERMINING A HAPTEN, AND ANALYTICAL METHOD FOR PERFORMING THE METHOD. | |
JPH05203646A (en) | Isolated type analyte assay | |
US9891214B2 (en) | Immunological assay method | |
EP0040224A1 (en) | An improved method of non homogenous enzyme immunoassay | |
EP0253270B1 (en) | Method for diagnostic immunoassay by solid phase separation | |
EP0565949A2 (en) | Method for the quantitative determination of a free form of substances present in biological fluids | |
AU6572180A (en) | An improved method of non-homogenous enzyme immunoassay | |
JPH0326787B2 (en) | ||
JPH0727764A (en) | Antibody for immunological measurement blocking fc part, reagent for immunological measurement containing said antibody, immunological measuring method using said reagent for immunological measurement and block reagent blocking fc part |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19810810 |
|
AK | Designated contracting states |
Designated state(s): DE FR GB NL SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19831129 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: DUFFY, PATRICK |